[DGlp1,DPhe2,DTrp3,6]-LH-RH

Names

[ Name ]:
[DGlp1,DPhe2,DTrp3,6]-LH-RH

[Synonym ]:
D-pglu1,D-phe2,D-trp3,6-luteinizing*hormone relea
pglu(1)-phe(2)-trp(3,6)-lhr
LHRH,pGlu(1)-Phe(2)-Trp(3,6)
[D-PGLU1,D-PHE2,D-TRP3,6]-LH-RH
[D-PYR1,D-PHE2,D-TRP3,6]-LH-RH (HUMAN)
(D-PYR1,D-PHE2,D-TRP3,6)-LHRH
DGLP-DPHE-DTRP-SER-TYR-DTRP-LEU-ARG-PRO-GLY-NH2
[D-PYROGLU1,D-PHE2,D-TRP3,6]-LH-RH
(D-Pyr1,D-Phe2,D-Trp3

Biological Activity

[Description]:

[D-Glp1,D-Phe2,D-Trp3,6]-LH-RH is a Luteinizing-hormone-releasing hormone (LHRH) analogue. [D-Glp1,D-Phe2,D-Trp3,6]-LH-RH acts as a GnRH receptor antagonist[1].

[Related Catalog]:

Signaling Pathways >> GPCR/G Protein >> GNRH Receptor

Research Areas >> Endocrinology

[Target]

GnRH receptor[1]

[In Vitro]

[D-Glp1,D-Phe2,D-Trp3,6]-LH-RH (1 μM), together with LH-RH and FSH, blocks the inhibition of FSH-induced steroidogenesis in rat ovary granulosa cells[3].

[In Vivo]

[D-Glp1,D-Phe2,D-Trp3,6]-LH-RH (1.25 and 2.5 mg, subcutaneous injection, b.i.d, for 7 days) prolongs pregnancy in rats[1]. [D-Glp1,D-Phe2,D-Trp3,6]-LH-RH (250 μg) inhibits ovulation by 100% in rats[2].

Chemical & Physical Properties

[ Molecular Formula ]:
C₆₇H₈₄N₁₆O₁₃

[ Molecular Weight ]:
1321.48000

[ Exact Mass ]:
1320.64000

[ PSA ]:
459.24000

[ LogP ]:
4.47690

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS08

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H360

[ Precautionary Statements ]:
P201-P308 + P313

[ Personal Protective Equipment ]:
Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ Hazard Codes ]:
T: Toxic;

[ Risk Phrases ]:
R60

[ Safety Phrases ]:
53-22-36/37/39-45

[ RIDADR ]:
NONH for all modes of transport

Articles

Characterization of Leydig cell gonadotropin-releasing hormone binding sites utilizing radiolabeled agonist and antagonist.

Peptides 3(5) , 789-92, (1982)

Gonadotropin-releasing hormone (GnRH) binding sites in intact Leydig cells and in membrane preparations were investigated using 125I-labeled GnRH agonist and antagonist. Binding was saturable and invo...

Role of lipids in gonadotropin releasing hormone agonists and antagonist binding to rat pituitary.

Biochem. Biophys. Res. Commun. 105(1) , 8-13, (1982)

Digestion of pituitary membranes with phospholipase A 2 and phospholipase C abolished, in a dose responsive manner, the specific binding of gonadotropin releasing hormone agonist and antagonist. These...

LH-RH analogue acts as substance P antagonist by inhibiting spinal cord vasomotor responses.

Brain Res. 337(2) , 357-61, (1985)

Intrathecal injections of the luteinizing hormone-releasing hormone (LH-RH) analogue, [D-pGlu1-D-Phe2-D-Trp3,6]-LH-RH caused dose-dependent decreases in mean arterial blood pressure in anesthetized ra...

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.